跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
茚达特罗莫米松吸入粉雾剂(Ⅰ) - NMPA Drug Approval Details
Approvals
/
NMPA
/
Indacaterol Acetate and Mometasone Furoate Powder for Inhalation(I)
Approved
化学药品
Indacaterol Acetate and Mometasone Furoate Powder for Inhalation(I)
GRAND MEDICAL PTY LTD.
🇨🇳 National Medical Products Administration
Approval Date
Jun 18, 2021
Approval ID
887Ae2MJCLM
Company
GRAND MEDICAL PTY LTD.
Type
化学药品
Approval Details
Approval Id
887Ae2MJCLM
Approval Number
国药准字HJ20210046
Generic Name
茚达特罗莫米松吸入粉雾剂(Ⅰ)
Generic Name En
Indacaterol Acetate and Mometasone Furoate Powder for Inhalation(I)
Drug Type
化学药品
Dosage Form
吸入粉雾剂
Strength
每粒含醋酸茚达特罗150μg(以 C₂₄H₂₈N₂O₃计)和糠酸莫米松80μg。
Reg Date
2021-06-18
Expired Date
2026-06-17
Company Name
GRAND MEDICAL PTY LTD.
Company Detail Path
/organization/grand-medical-pty-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 18, 2021
Approval ID
887Ae2MJCLM
Type
化学药品
Back to NMPA Approvals